Ponesimod
VP-VSP-128-3102
Phase 3 small_molecule active
Quick answer
Ponesimod for Moderate-to-severe Chronic Plaque Psoriasis is a Phase 3 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Moderate-to-severe Chronic Plaque Psoriasis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active